 NEW YORK--BUSINESS WIRE--CM Life Sciences II Inc. the Company announced today that it priced its initial public offering of 24,000,000 units at 10.00 per unit. The units will be listed on The Nasdaq Capital Market Nasdaq and trade under the ticker symbol CMIIU beginning February 23, 2021. Each unit consists of one share of Class A common stock and one-fifth of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of 11 